Dr. Nimish Patel's main research interest involves evaluating clinical outcomes associated with anti-infective medications. Dr. Patel's research encompasses three domains: 1) comparative safety and effectiveness of antimicrobials in real-world settings, 2) predictors and outcomes of patients with contraindicated drug-drug interactions and 3) pharmacoeconomic strategies of emerging antimicrobial agents that result in a cost savings relative to existing medications associated with a high frequency of costly toxicities or prolonged hospitalization. Dr. Patel's clinical areas of expertise are treatment of hospitalized patients with infectious diseases, pharmacokinetic monitoring of antimicrobials, antibiotic stewardship, HIV consult service and hepatitis C. Some of his current research projects include: real-world safety and effectiveness of fluoroquinolones versus ceftriaxone/azithromycin for patients with community acquired pneumonia, incidence and predictors of outcomes among patients with diabetic foot infections, and effect of exogenous hormones on renal function and drug concentrations in transgender patients using pre-exposure prophylaxis